Delivery Order SPE2DB24D2205-SPE2DB25FEAFL
Award Date
3/28/25
Potential Completion Date
4/18/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NUBEQA 300 MG TABLET 120S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,518.40, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2024. The contract has an ultimate completion date of August 6, 2024 and is structured as a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen holds several Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to the U.S. government. The contract, valued at $7,641.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract, valued at $3,518.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a federal agency within the Department of Defense. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 4567881031 NUBEQA 300 MG TABLET 120S. This is a firm fixed-price delivery order contract with a completion date of May 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen is the prime contractor for this award. The company holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,641.98, is for the delivery of the drug NUBEQA 300 MG TABLET 120S. The contract is a firm-fixed price delivery order with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, valued at $4,845.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is December 31, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564234346 - NUBEQA 300 MG TABLET 120S, a specialty pharmaceutical product, over a period ending on May 1, 2024. The contract has a firm fixed price ceiling value of $3,518.40. This award is a delivery order under a larger indefinite...